-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals only
Eliminate the high false positive of CT scan, to hear what Professor Leung Wenhua said?
With the popularity of low-dose CT scans, more and more people are "discovered" to have one or more nodules on their lungs, and the early manifestation of lung cancer is lung nodules
Counteracts the risk of false positives on CT scans
Lung cancer is one of the most common tumors, and early diagnosis is an effective way
New combined screening model for higher clinical availability
In addition to judging the accuracy and sensitivity of the PulmoSeek Plus model, Professor Liang's team also compared the existing lung nodule diagnosis models, such as the Mayo model and the Brock model
Liang Wenhua
Professor/PhD Supervisor/Deputy Chief Physician
Department of Thoracic Oncology, First Affiliated Hospital of Guangzhou Medical University
Winner of the National Youth Fund (Oncology), a young Pearl River scholar, and an outstanding young medical talent in Guangdong
Assistant to the President of Guangzhou Institute of Respiratory Health, Director of the Office of the National Center for Respiratory Medicine
Deputy Leader of the Lung Cancer Group of the State Key Laboratory of Respiratory Diseases
Chairman of the Immunotherapy Committee of Guangdong Society of Chest Diseases
Vice Chairman of the Precision Medicine and Molecular Diagnostics Branch of Guangdong Medical Association
He is a youth member of the Chinese Society of Clinical Oncology (CSCO), a member of the NSCLC Special Committee, and a member of the Lung Cancer Guidelines Expert Group
Associate Editor, Transl Lung Cancer Res, Editorial Board of J Thorac Dis and Ann Transl Med
Mainly engaged in the comprehensive diagnosis and treatment of lung cancer and clinical translational research
Won the ASCO Merit Award, People's Network 'Famous Doctor of the Country', CSCO National 35 Most Promising Young Oncologists, 2020 Ali Dharma Academy Green Orange Award (first place in medicine), as one of the main finishers, won the second prize of the National Science and Technology Progress Award, the innovation team, and the national innovation competition medal
Literature references:
[1]https://oncologypro.
[2] Ostrowski M,Marjanski T,Rzyman W.
